Sponsor Pipeline

Sinotau Pharmaceutical Group Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
6
Recruiting
4
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
3
Phase 2/3
1
Phase 2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07115238 Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI… Alzheimer Disease Recruiting
NCT07439133 Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of… Coronary Artery Disease(CAD) Recruiting
NCT05459844 A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide… Neuroendocrine Tumors Active, Not Recruiting
Phase 2/3
NCT06398444 A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced… Advanced Neuroendocrine Neoplasm Recruiting
Phase 2
NCT07443696 PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess… Ischemic Cardiomyopathy Recruiting
Phase 1
NCT07149831 A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation… Prostate Cancer Recruiting
Not specified
NCT07115277 Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With… Prostate Cancer Recruiting
Disease Areas
Get alerts when Sinotau Pharmaceutical Group's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free